regulatory approval

News

Close-up view of an actinic keratosis lesion

FDA OKs wider use of Almirall’s actinic keratosis drug

With actinic keratosis (AK) diagnoses on the rise, there is some good news for patients, with the FDA approval of expanded use of Almirall’s topical therapy Klisyri.

News

Geron finally brings a drug to market as FDA clears Rytelo

More than 30 years after it was first founded, Geron has claimed FDA approval for its first product – myelodysplastic syndromes (MDS) treatment Rytelo.

News

Moderna gets FDA okay for RSV vaccine mResvia

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax C

News

Lilly’s Retevmo cleared for RET-positive child cancers

The US FDA has given accelerated approval for Eli Lilly’s RET inhibitor as a treatment for various RET-altered paediatric cancers, making it the first drug in the class av

News

FDA clears Amgen’s Bkemv as first biosimilar of Soliris

The US FDA has approved the first biosimilar version of AstraZeneca/Alexion’s Soliris therapy for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemi

News

Lung disease imaging AI from Brainomix gets FDA nod

Artificial intelligence company Brainomix has claimed FDA approval for e-Lung, which assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from me

FDA OKs wider use of Almirall’s actinic keratosis drug

Geron finally brings a drug to market as FDA clears Rytelo

Moderna gets FDA okay for RSV vaccine mResvia

Lilly’s Retevmo cleared for RET-positive child cancers

FDA clears Amgen’s Bkemv as first biosimilar of Soliris

Lung disease imaging AI from Brainomix gets FDA nod

Are Makary's priority review vouchers about to be canned?

Securing your ROI: Turning post-acquisition integration into...

regulatory approval

Editor's Picks